Welcome to Retina International

Retina International welcomes EMA’s approval of voretigene neparvovec (Luxturna), a gene therapy for the treatment of LCA, in Europe


What We Do

For almost 40 years, Retina International (RI) has been the voice of patient-led voluntary groups, charities and foundations world wide who fund and support Retinal Research that is seeking a cure for Retinitis Pigmentosa (RP), Macular Degeneration, Ushers Syndrome & Allied Retinal Dystrophies.

Inherited Retinal Disease Toolkit

An educational resource designed for patients with IRDs, their representatives and their healthcare professionals to address the challenges of vision health and blindness.

Find out more

AMD Toolkit

An educational toolkit for a multi-stakeholder audience related to Age-related Macular Degeneration

Find out more

Sending a Red Alert!

A Toolkit on Genetic Testing Services to Inform those with Rare Eye Disease

Find out more

Diabetic Eye Disease Toolkit

 

Coming soon

Patient Information

Learn more about your eyes and the many inherited, rare and genetic forms of sight loss as well as age related and common diseases of the Retina.


Learn More

Become a Member

Learn how you can become a member of our community

Learn More

Join Our Mailing List

To keep up to date with our news and activities, please complete this simple form

Retina International
Ausstellungsstr. 36
8005 Zurich
Switzerland

Follow Us
Twitter
Youtube

This site has been supported through an unrestricted educational grant from Novartis

Novartis
Font Resize
High Contrast